{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:10282"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:10282","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The effect of Obstructive Sleep Apnoea (OSA) on health outcomes in patients with asthma: epidemiology, impact on asthma control, and effect of treatment using Continuous Positive Airway Pressure (CPAP)","abstract":"Introduction: The aim was to determine the prevalence of OSA in severe asthma (SA), the effect of OSA and the impact of CPAP treatment on asthma-related clinical outcomes. Methods: Systematic review (SR) of the pre-existing literature, a cross-sectional study, prospective case-control study and a randomised, double-blind, placebo-controlled pilot feasibility study (RCT) were conducted. Results: SR; 6 studies: 19-60% prevalence in asthma, 50-95% in SA, 13 questionnaire studies; 8-53% prevalence in asthma. Observational studies; 191 participants, 70% prevalence. Asthma-related quality of life, asthma control, depression scores and general quality of life worsened with increasing severity of OSA. SR; CPAP treatment can improve asthma-related quality of life particularly in more severe asthma or severe OSA. RCT; 27 participants recruited, 14 completed study. No change in AQLQ or asthma control with CPAP, but small numbers recruited with high drop-out rate (48%). Conclusion: A high prevalence of OSA in asthma, and particularly severe asthma exists with negative impact on asthma control and quality of life. Improved asthma-related quality of life with CPAP treatment has been observed, but this was not supported with the RCT. Further research with a large multicentre RCT is needed before firm conclusions can be made on the impact of CPAP treatment.","abstract_html":"Introduction: The aim was to determine the prevalence of OSA in severe asthma (SA), the effect of OSA and the impact of CPAP treatment on asthma-related clinical outcomes. Methods: Systematic review (SR) of the pre-existing literature, a cross-sectional study, prospective case-control study and a randomised, double-blind, placebo-controlled pilot feasibility study (RCT) were conducted. Results: SR; 6 studies: 19-60% prevalence in asthma, 50-95% in SA, 13 questionnaire studies; 8-53% prevalence in asthma. Observational studies; 191 participants, 70% prevalence. Asthma-related quality of life, asthma control, depression scores and general quality of life worsened with increasing severity of OSA. SR; CPAP treatment can improve asthma-related quality of life particularly in more severe asthma or severe OSA. RCT; 27 participants recruited, 14 completed study. No change in AQLQ or asthma control with CPAP, but small numbers recruited with high drop-out rate (48%). Conclusion: A high prevalence of OSA in asthma, and particularly severe asthma exists with negative impact on asthma control and quality of life. Improved asthma-related quality of life with CPAP treatment has been observed, but this was not supported with the RCT. Further research with a large multicentre RCT is needed before firm conclusions can be made on the impact of CPAP treatment.","abstract_has_math":false,"creators":["Davies, Sarah Elizabeth"],"institution":"University of Birmingham","degree_name":"d_m_d","degree_level":"d_m_d","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-07","date_published":"2020-07","updated_at":"2026-11-19T09:31:05Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/10282/7/Davies2020MD_Redacted.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A10282","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Davies, Sarah Elizabeth"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-07-20"]},{"key":"dc:date.issued","label":"Date","values":["2020-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Inflammation & Ageing"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/10282/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_m_d"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_m_d"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/10282/7/Davies2020MD_Redacted.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Introduction: The aim was to determine the prevalence of OSA in severe asthma (SA), the effect of OSA and the impact of CPAP treatment on asthma-related clinical outcomes. Methods: Systematic review (SR) of the pre-existing literature, a cross-sectional study, prospective case-control study and a randomised, double-blind, placebo-controlled pilot feasibility study (RCT) were conducted. Results: SR; 6 studies: 19-60% prevalence in asthma, 50-95% in SA, 13 questionnaire studies; 8-53% prevalence in asthma. Observational studies; 191 participants, 70% prevalence. Asthma-related quality of life, asthma control, depression scores and general quality of life worsened with increasing severity of OSA. SR; CPAP treatment can improve asthma-related quality of life particularly in more severe asthma or severe OSA. RCT; 27 participants recruited, 14 completed study. No change in AQLQ or asthma control with CPAP, but small numbers recruited with high drop-out rate (48%). Conclusion: A high prevalence of OSA in asthma, and particularly severe asthma exists with negative impact on asthma control and quality of life. Improved asthma-related quality of life with CPAP treatment has been observed, but this was not supported with the RCT. Further research with a large multicentre RCT is needed before firm conclusions can be made on the impact of CPAP treatment."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["The effect of Obstructive Sleep Apnoea (OSA) on health outcomes in patients with asthma: epidemiology, impact on asthma control, and effect of treatment using Continuous Positive Airway Pressure (CPAP)"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Davies, Sarah Elizabeth"],"dc:date":["2020-07-20"],"dc:date.issued":["2020-07"],"dc:description.abstract":["Introduction: The aim was to determine the prevalence of OSA in severe asthma (SA), the effect of OSA and the impact of CPAP treatment on asthma-related clinical outcomes. Methods: Systematic review (SR) of the pre-existing literature, a cross-sectional study, prospective case-control study and a randomised, double-blind, placebo-controlled pilot feasibility study (RCT) were conducted. Results: SR; 6 studies: 19-60% prevalence in asthma, 50-95% in SA, 13 questionnaire studies; 8-53% prevalence in asthma. Observational studies; 191 participants, 70% prevalence. Asthma-related quality of life, asthma control, depression scores and general quality of life worsened with increasing severity of OSA. SR; CPAP treatment can improve asthma-related quality of life particularly in more severe asthma or severe OSA. RCT; 27 participants recruited, 14 completed study. No change in AQLQ or asthma control with CPAP, but small numbers recruited with high drop-out rate (48%). Conclusion: A high prevalence of OSA in asthma, and particularly severe asthma exists with negative impact on asthma control and quality of life. Improved asthma-related quality of life with CPAP treatment has been observed, but this was not supported with the RCT. Further research with a large multicentre RCT is needed before firm conclusions can be made on the impact of CPAP treatment."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/10282/7/Davies2020MD_Redacted.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Inflammation & Ageing"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/10282/"],"dcterms:accessrights":["public"],"dc:title":["The effect of Obstructive Sleep Apnoea (OSA) on health outcomes in patients with asthma: epidemiology, impact on asthma control, and effect of treatment using Continuous Positive Airway Pressure (CPAP)"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_m_d"],"dc:type.qualificationname":["d_m_d"]},"updated_at":"2026-11-19T09:31:05Z"}